Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [517]
News [1432]
Articles [66]
Editorials [2]
Conferences [72]
elearning [5]
MEK inhibitor trametinib added to the BRAF inhibitor dabrafenib improves melanoma outcome
MEK inhibitor trametinib added to the BRAF inhibitor dabrafenib improves melanoma outcome
Scientists find molecular 'breadcrumb trail' that helps melanoma spread
Scientists find molecular 'breadcrumb trail' that helps melanoma spread
Deaths from thin melanomas on the rise
Deaths from thin melanomas on the rise
Intralesional injections show promise for cutaneous melanoma
Intralesional injections show promise for cutaneous melanoma
ESMO 2014: Nivolumab shows signs of superior response rate compared to standard chemo in advanced melanoma
ESMO 2014: Nivolumab shows signs of superior response rate compared to standard chemo in advanced melanoma
ESMO 2014: Improved response rate and survival with dabrafenib plus trametinib versus vemurafenib alone in melanoma
ESMO 2014: Improved response rate and survival with dabrafenib plus trametinib versus vemurafenib alone in melanoma
ESMO 2014: Vemurafenib plus cobimetinib achieves significant progression-free survival in melanoma
ESMO 2014: Vemurafenib plus cobimetinib achieves significant progression-free survival in melanoma
Calming down immune cells could hold key to melanoma treatment
Calming down immune cells could hold key to melanoma treatment
Exercise boosts tumour-fighting ability of chemotherapy
Exercise boosts tumour-fighting ability of chemotherapy
NICE approves dabrafenib for BRAF V600 advanced melanoma
NICE approves dabrafenib for BRAF V600 advanced melanoma

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation